Nanoparticle‐microglial interaction in the ischemic brain is modulated by injury duration and treatment
Abstract Cerebral ischemia is a major cause of death in both neonates and adults, and currently has no cure. Nanotechnology represents one promising area of therapeutic development for cerebral ischemia due to the ability of nanoparticles to overcome biological barriers in the brain. ex vivo injury...
Saved in:
Main Authors: | Andrea Joseph (Author), Rick Liao (Author), Mengying Zhang (Author), Hawley Helmbrecht (Author), Michael McKenna (Author), Jeremy R. Filteau (Author), Elizabeth Nance (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A ferret brain slice model of oxygen-glucose deprivation captures regional responses to perinatal injury and treatment associated with specific microglial phenotypes
by: Thomas R. Wood, et al.
Published: (2022) -
Ambient Temperature Is Correlated With the Severity of Neonatal Hypoxic-Ischemic Brain Injury via Microglial Accumulation in Mice
by: Rika Zen, et al.
Published: (2022) -
Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury
by: Tengfei Xue, et al.
Published: (2022) -
Brain Iron Homeostasis: A Focus on Microglial Iron
by: Israel C. Nnah, et al.
Published: (2018) -
Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy
by: Andrea Joseph, et al.
Published: (2021)